Whilst further work will be required to dissect the reasons for these cell type-specific differences, since increased PD risk seems to correlate with increased RAB7L1 expression (Beilina et al., 2014), our findings may have implications for targeting LRRK2 kinase activity also in RAB7L1-related idiopathic PD. This evidence concerns the gene RAB29 and Parkinson disease.